Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03781960
Title Abemaciclib and Nivolumab for Subjects With Hepatocellular Carcinoma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Abramson Cancer Center of the University of Pennsylvania
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST